InvestSMART

Terragen Holdings Limited (ASX:TGH)

ALERT: Price-sensitive ASX Announcement for TGH
Current share price for TGH : $0.022 -0.002 (-8.33%)+
Announcement
Release
30 Apr 2026 8:19AM
Price at Release
$0.024
Full Release
download
Summary
Terragen Holdings Limited, an Australian company specializing in the development of biological products for agricultural applications, released its quarterly activities report and Appendix 4C for the three months ended 31 March 2026. Key highlights include the completion of a successful equity raise of $7.1 million, with significant contributions from directors and investors, and a 12% yield increase in maize silage using their biostimulant Great Land Plus®. The company conducted various trials, including a major probiotic trial for ruminants. Financially, Terragen reported a net cash inflow from financing activities and maintained robust cash reserves of $8.4 million. The company continues to advance its commercialization strategy for its products in Australia and New Zealand and is engaging in research collaborations to develop nitrogen-fixing solutions.
Key Points
  • Successful equity raise of $7.1 million.
  • 12% yield increase in maize silage using Great Land Plus®.
  • Independent field trials showing improved dry matter yield with GLP.
  • Advancement in nitrogen-fixing solution in collaboration with QUT.
  • Financial reserves increased to $8.4 million.
  • Continued commercialization strategy for products in Australia and New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.